Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Biolex Therapeutics patents

List of Biolex Therapeutics patents

List of Indevr, Inc. patents

List of Infinite Biomedical Technologies, LLC patents

List of Intelligent Automation, Inc. patents

List of companies in Musha Ventures's investment portfolio

List of awards received by Frank Rijkaard

Patents where

Current Assignee

Name

is

Biolex Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7884264 Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plants	Patent 7884264 was granted and assigned to Biolex Therapeutics on February, 2011 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	7884264	February 8, 2011
	‌ US Patent 7326385 Plate and method for high throughput screening	Patent 7326385 was granted and assigned to Biolex Therapeutics on February, 2008 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	7326385	February 5, 2008
	‌ US Patent 7632983 Expression of monoclonal antibodies in duckweed	Patent 7632983 was granted and assigned to Biolex Therapeutics on December, 2009 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	7632983	December 15, 2009
	‌ US Patent 7709699 Use of duckweed in high throughput screening	Patent 7709699 was granted and assigned to Biolex Therapeutics on May, 2010 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	7709699	May 4, 2010
	‌ US Patent 7659445 Expression of plasminogen and microplasminogen in duck weed	Patent 7659445 was granted and assigned to Biolex Therapeutics on February, 2010 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	7659445	February 9, 2010
	‌ US Patent 7736674 Controlled release compositions for interferon based on PEGT/PBT block copolymers	Patent 7736674 was granted and assigned to Biolex Therapeutics on June, 2010 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	7736674	June 15, 2010
	‌ US Patent 8137661 Controlled release interferon drug products and treatment of HCV infections using same	Patent 8137661 was granted and assigned to Biolex Therapeutics on March, 2012 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	8137661	March 20, 2012
	‌ US Patent 8034916 Expression control elements from the	Patent 8034916 was granted and assigned to Biolex Therapeutics on October, 2011 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	8034916	October 11, 2011
	‌ US Patent 8022270 Expression of biologically active polypeptides in duckweed	Patent 8022270 was granted and assigned to Biolex Therapeutics on September, 2011 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	8022270	September 20, 2011
	‌ US Patent 8182803 C-terminally truncated interferon alpha variants	Patent 8182803 was granted and assigned to Biolex Therapeutics on May, 2012 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	8182803	May 22, 2012
	‌ US Patent 7915483 C-terminally truncated interferon	Patent 7915483 was granted and assigned to Biolex Therapeutics on March, 2011 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	7915483	March 29, 2011
	‌ US Patent 7867518 Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereof	Patent 7867518 was granted and assigned to Biolex Therapeutics on January, 2011 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	7867518	January 11, 2011
	‌ US Patent 8017836 Expression of plasminogen and microplasminogen in duckweed	Patent 8017836 was granted and assigned to Biolex Therapeutics on September, 2011 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	8017836	September 13, 2011
	‌ US Patent 7959910 C-terminally truncated interferon alpha variants	Patent 7959910 was granted and assigned to Biolex Therapeutics on June, 2011 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	7959910	June 14, 2011
	‌ US Patent 8163307 Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof	Patent 8163307 was granted and assigned to Biolex Therapeutics on April, 2012 by the United States Patent and Trademark Office.		Biolex Therapeutics		United States Patent and Trademark Office	8163307	April 24, 2012

15 results

0 selected

15 results

0 selected